1 Result(s)

Article

Safety and Effectiveness of SB2 (Infliximab Biosimilar) in Adult Patients with Immune-Mediated Inflammatory Diseases: A Post-Marketing Surveillance in Korea

SB2 is a biosimilar of infliximab (IFX), which is approved for rheumatoid arthritis (RA), ankylosing spondylitis (AS), adult and pediatric Crohn’s disease (CD), adult and pediatric ulcerative colitis (UC), pso...

Dong W. Kim, Yousun Lee, Geuntae Kim, Sang H. Kim, Dae H. Cho… in Advances in Therapy (2023)